
Japan – NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment
NEC Corporation (NEC; TSE: 6701), in collaboration with Chugai Pharmaceutical Co., Ltd., has conducted an experiment using AI to predict drug combinations that can possibly enhance the effectiveness of certain cancer treatments. As a result, the time …